Knee Osteoarthritis in the Region of Norrbotten
Launched by UMEÅ UNIVERSITY · Jun 4, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Knee Osteoarthritis in the Region of Norrbotten," is focused on understanding knee osteoarthritis, especially in people who have experienced tibial plateau fractures (a type of knee injury). The study aims to find out how common knee osteoarthritis is in this region and to look at the long-term effects on patients' ability to function after their injury. Researchers also want to identify any risk factors that could affect recovery.
To participate, individuals need to be between the ages of 65 and 74 and have had a tibial plateau fracture between 2001 and 2015 in the Norrbotten region of Sweden. Unfortunately, if someone has had certain other knee conditions or injuries, or if they have cognitive issues that prevent them from understanding the study, they won't be eligible. Participants can expect to share their experiences and health information, which will help researchers better understand the impact of these injuries on quality of life. Overall, this study is important for improving future care for patients with knee injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients from the region of Norrbotten (northern part of Sweden) who underwent tibial plateau fracture between the years of 2001 and 2015
- Exclusion Criteria:
- • Death without bilateral weighted X-ray minimum 5 years post injury
- • Open growth plate in distal femur and/or proximal tibia
- • Extraarticular or isolated eminentia fracture
- • OA prior to injury
- • Having a rheumatic disorder involving joints
- • Earlier and/or later severe injury to the index knee
- • Having cognitive disorders disqualifying from the study
About Umeå University
Umeå University, a leading research institution in Sweden, is dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge technology and expert knowledge across various fields to address critical health challenges. Its commitment to ethical standards and patient safety ensures that all clinical trials conducted under its auspices are designed to generate robust scientific evidence, ultimately contributing to improved health outcomes and informed medical practices. Umeå University strives to foster a dynamic research environment that supports the development of new therapies and enhances the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Luleå, Norrbotten, Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported